Radiotherapy (RT) is an integral part of the palliative management of malignancy. Delivery of palliative RT is a simpler process than with curative RT, as the treatment is less complex in planning and delivery, with the treatment course generally much shorter and of lower radiation dose, and associated with less toxicity as a result. Palliative RT is applicable to a wide range of pathologies and to both primary and secondary sites. Commonly treated primary sites include the bronchus, oesophagus, rectum, bladder, and cervix. Secondary sites most often treated are skeletal, brain, and epidural (spinal cord compression). Palliative RT can be delivered in conjunction with surgical management or as an alternative management approach.
IntroductionRadiation oncology plays an integral role in cancer management as one of the three recognised disciplines together with surgical oncology and medical oncology. Radiation oncology is responsible for delivery of the treatment modality of radiotherapy (RT), principally used for neoplastic conditions, but much less frequently, benign conditions are also managed with RT. RT is an effective management for cancer in both the curative and palliative settings. The optimal utilisation rate of radiotherapy, prescribed at least once over the cancer journey for all patients diagnosed with cancer, has been calculated at 52 % [ 1 ].